ETFdb Logo
ETFdb Logo
  • ETF Database
  • Channels
    • Active ETF
    • Alternatives
    • Beyond Basic Beta
    • China Insights
    • Climate Insights
    • Commodities
    • Core Strategies
    • Crypto
    • Disruptive Technology
    • Dividend
    • Dual Impact
    • Emerging Markets
    • Energy Infrastructure
    • ESG
    • ETF Building Blocks
    • ETF Education
    • ETF Strategist
    • Fixed Income
    • Free Cash Flow
    • Future ETFs
    • Global Diversification
    • Gold/Silver/Critical Minerals
    • Innovative ETFs
    • Institutional Income Strategies
    • Leveraged & Inverse
    • Managed Futures
    • Market Insights
    • Megatrends
    • Modern Alpha
    • Multi-Asset
    • Night Effect
    • Portfolio Strategies
    • Retirement Income
    • Richard Bernstein Advisors
    • Tax Efficient Income
    • Thematic Investing
    • Volatility Resource
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Sector Tracker Tool
    • ETF Database Categories
    • Head-To-Head ETF Comparison Tool
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
    • Indexes
    • Mutual Fund To ETF Converter
    • ETF Data for Journalists
    • ETF Nerds
  • Research
    • First Bitcoin ETF
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Themes
    • AI ETFs
    • Blockchain ETFs
    • See all Thematic Investing ETF themes
    • ESG Investing
    • Marijuana ETFs
  • Multimedia
    • ETF 360 Video Series
    • ETF Trends on Videos
    • ETF Trends on Podcasts
    • ETF Prime Podcast
  • Company
    • About Us
    • Swag Store
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Pricing
    • Free Sign Up
    • Login
  1. Future ETFs Channel
  2. Go With GDOC as Healthcare Revolution Heats Up
Future ETFs Channel
Share

Go With GDOC as Healthcare Revolution Heats Up

Tom LydonSep 06, 2022
2022-09-06

Investors who haven’t been paying attention may not be up to date on some important points about the healthcare sector. This isn’t your grandfather’s healthcare sector, and the group is home to an increasingly innovative spirit.

While those may sound like superficial points, there are important investment implications, many of which are relevant to select exchange traded funds. That group includes the Goldman Sachs Future Health Care Equity ETF (GDOC B-).

GDOC is an actively managed ETF, and for investors looking to be on the right side of healthcare innovation, that’s a relevant trait because many of the passive funds in this category aren’t adequately exposed to the growthier corners of the healthcare sector. As an active fund, GDOC can provide and boost exposure to life sciences, many of which are driving the next generation of healthcare innovation.

“Life Sciences is currently the largest sector within the healthcare industry and has continued to expand rapidly, with heightened demand for therapeutics driven by aging demographics and the rising prevalence of chronic disease,” noted Goldman Sachs Asset Management.

Life sciences, which includes biotechnology and pharmaceuticals, is the largest part of the healthcare sector, and the long-term outlook for those industries is compelling.

“The COVID-19 pandemic highlighted the importance and impact of the innovation and structural changes that are driving LS growth globally. We believe the current landscape provides opportunities to drive research forward in critical LS areas and explore new avenues for streamlining drug development and approval processes,” added GSAM.

Investors have often considered large-cap biotech and pharmaceuticals to be mature, steady, but slower growth outfits. Owing to active management, GDOC is home to some blue-chip pharma companies, which serves as a volatility-reducing quality-enhancing trait.

Still, the Goldman Sachs ETF has ample leverage to mid-sized, nimble companies that could be among the next generation of great life sciences growth stories. Another point in the ETF’s favor is its intersection with other disruptive technologies, which bolsters its long-term investment thesis.

“Advancements in the understanding of disease and a convergence of innovation across many scientific disciplines are enabling the development of new drug platforms that create novel ways to treat disease and solve patients’ unmet needs. Separately, regulatory bodies are creating policies to better leverage new technology and create new approval pathways, with a concerted effort in many geographies to support domestic LS innovation and development,” concluded GSAM.

For more news, information, and strategy, visit the Future ETFs Channel.

Loading Articles...
Help & Info
  • Contact Us
Tools
  • ETF Screener
  • ETF Analyzer
  • Mutual Fund to ETF Converter
  • Head-To-Head ETF Comparison
  • ETF Country Exposure Tool
  • ETF Stock Exposure Tool
  • ETF Performance Visualizer
  • ETF Database Model Portfolios
  • ETF Database Realtime Ratings
  • ETF Database Pro
More Tools
  • ETF Launch Center
  • Financial Advisor & RIA Center
  • ETF Database RSS Feed
Explore ETFs
  • ETF News
  • ETF Picks of the Month
  • ETF Category Reports
  • Premium Articles
  • Alphabetical Listing of ETFs
  • Best ETFs
  • Browse ETFs by ETF Database Category
  • Browse ETFs by Index
  • Browse ETFs by Issuer
  • Compare ETFs
Legal
  • Terms of Use and Privacy Policy
  • © 2023 VettaFi LLC. All rights reserved.
Follow ETF Database
Follow ETF Database

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X